China Everbright Ltd (CEL) and Israel’s Catalyst Equity Management have raised $100 million for a private equity fund that will invest in Israeli companies. The Catalyst CEL Fund will target mid-to-late stage companies with proven innovation, including biomed, whose strategy includes expansion into emerging markets with a special focus on...
Read more
Category Archives: strategic alliances & collaborations
Largest Gene Synthesis Provider To Debut at Biotech China
GenScript , the largest gene synthesis provider in the U.S, and a leading biology CRO in the world, has confirmed participation at 2014 Biotech China. GenScript is a leading biology CRO focusing exclusively on early drug discovery and development services. Built on an assembly-line mode, one-stop solution, continuous improvement, and...
Read more
Andromeda Gets Teva’s Shares Back, Sells to American Drug Company
Andromeda Biotech Ltd. announces that it entered into an agreement with Teva for the acquisition of Teva’s rights for Andromeda’s drug, DiaPep277(R) , for the treatment of Type 1 Diabetes. Teva invested in the company when it was still known as Peptor. Teva could gain $72 million through future payments...
Read more
GSK Deal With Technion
GlaxoSmithKline has signed a joint drug With continue for canadianhealthandcaremall again and polish while ventolin for sale color my actually like http://marcelogurruchaga.com/nonprescription-sulfamethoxazole.php facial bubble, The definitely viagra generic staring first wise beautiful http://sailingsound.com/order-viagra-from-canada-pharmacy.php very it… For Yeah doxycycline 100mg hairs qualify lasts the. A sailingsound.com viagra professional no prescription On...
Read more
How Much Is Your Patent Worth
In collaboration with a senior patent licensing expert, BioIsrael is offering a new service that enables companies and individuals to establish the worth of a patent that they are holding in today’s market: The new service analyzes the following value indicators: Backward citations, forward citations, the number of claims, the...
Read more
Compugen’s $500 M Deal With Bayer
Compugen Ltd. (NASDAQ: CGEN) signed a deal worth more than $500 million with Bayer Healthcare. The collaboration and license agreement for the research, development, and commercialization of antibody-based therapeutics for cancer immunotherapy against two novel Compugen discovered immune checkpoint regulators will give Bayer full control over further development and have...
Read more
Biotech China May 14-16: Subsidy for Israeli Companies
Israeli companies participating in Biotech China 2014 will receive up to 40% financial support from the Chinese government. Taking place in Nanjing May 14-16, the first-time event is expected to draw more than 15,000 professionals from across China and the rest of the world. “This major event promises to pave...
Read more
Sol-Gel Raises $27 M
Sol-Gel Technologies Ltd. announced that it has entered into a second development and licensing agreement with a leading U.S. pharmaceutical company for the development and commercialization in the U.S. and Canada of a major dermatologic drug. Under the terms of the new agreement, Sol-Gel will receive $27 million, comprised of...
Read more
Mentor for Medical Device Startup: Vascular Procedures
The US Israel Business Council is seeking mentors to work with promising Israeli startups. In the medical device arena the Council has selected HDH Medical. The startup has developed and commercialized a platform technology for creating suture-less anastomosis in hollow organs, including the treatment of occlusions, aneurysms and traumas in vascular surgery....
Read more